Aegon N.V. : Major technical obstacle ahead that will put the market into pause mode
| Entry price | Target | Stop-loss | Potential |
|---|
|
€4.02 |
€3.7 |
€4.23 |
+7.96% |
|---|
Aegon N.V. shares are trading close to a major resistance on the weekly chart around 4.05 EUR. A short term correction would be a logical consequence.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The stock, which is currently worth 2019 to 0.67 times its sales, is clearly overvalued in comparison with peers.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● The company is one of the best yield companies with high dividend expectations.
● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
● The stock is close to a major daily resistance at EUR 4.03, which should be gotten rid of so as to gain new appreciation potential.
● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
● For the last few months, analysts have been revising downwards their earnings forecast.
● The underlying tendency is negative on the weekly chart below the resistance at 4.05 EUR
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
AEGON N.V. 
